Major pharmaceutical organizations in Greece, including the Association of Pharmaceutical Companies of Greece, warn that the new EU Directive on wastewater treatment could lead to significant drug shortages. The directive imposes heavy financial burdens on the pharmaceutical sector, mandating that it covers over 80% of costs related to removing pollutants from wastewater, regardless of their source. These groups argue that the new rules could restrict patient access to medications while not contributing effectively to environmental goals. They advocate for a fair and data-driven regulatory approach that addresses all contributors to pollution.

Source